Helicobacter pylori infection
Conditions
Interventions
Experimental group:Doxycycline (0.1g, twice a day) Caplacizumab 20mg twice a day, course of 14 days, can be adjusted if necessary.
Sponsors
NanJing First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 80 years; 2. Patients receiving regular hemodialysis; 3.Voluntary participation in the study and provision of written informed consent.
Exclusion criteria
Exclusion criteria: 1. Allergy to any study medication (e.g., keverprazan, doxycycline); 2. Pregnancy or lactation; 3. Alcohol abuse; 4. Hepatic insufficiency due to hepatitis, fatty liver, or other causes; 5. Presence of malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| H. pylori infection rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of side effects; | — |
Countries
China
Contacts
Public ContactZhang Zhenyu
NanJing First Hospital
Outcome results
None listed